ArticleTurkish journal of biology = Turk biyoloji dergisi2025
A tetracycline-inducible Split TurboID system for specific biotinylation and identification of nuclear proteins from HEK293T cells.
Article in Turkish journal of biology = Turk biyoloji dergisi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluating SH-SY5Y cells as a dopaminergic neuronal model: morphological, transcriptomic, and proteomic insights.Turkish journal of biology = Turk biyoloji dergisi · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/aim: To overcome the limitations of conventional organelle isolation methods including low purity, low yield, sample degradation, scalability and the need for multiple centrifugation steps, an improved nuclear protein enrichment approach was developed using the modified Split TurboID biotin ligase enzyme. Materials and methods: A construct was created in which the N-terminal domain of TurboID, fused to the FK506-binding protein (FKBP) was targeted to the nucleus. This construct was incorporated into a tetracycline-inducible gene expression vector. Similarly, the C-terminal domain of TurboID was fused to the rapamycin-binding domain of mTOR (FRB) and directed to the nucleus. This construct was introduced into a constitutive expression vector. A HEK-293T-TetR+ cell line, stably expressing both fusion proteins, was created. Activation of the N-terminal domain was achieved by tetracycline induction while an active Split-TurboID was formed within the nucleus only after the introduction of rapamycin into the culture medium which facilitated the formation of the FKBP-Rapamycin-FRB complex. Results: The cells expressed N- and C-termini of Split-TurboID and produced an active biotin ligase enzyme in the nucleus, as demonstrated by Western blot and immunofluorescence microscopy analyses. The active enzyme biotinylated both residential nuclear proteins and the proteins that transiently interact with the nucleus. Enrichment and identification of the biotinylated proteins showed that 1518 proteins were identified, of which 78.4% were localized to or colocalized with the nucleus. Comparison with unenriched samples confirmed higher confidence in identification of resident nuclear proteins. Cross-referencing with the Human Protein Atlas highlighted the limitations of current databases, 820 proteins match known nuclear proteins and 698 have not been previously annotated. Conclusion: Split-TurboID-based approach effectively minimized background noise arising from nonspecific labeling or imperfect localization and provided an appreciable level of specificity resulting identification of both residential and transiently interacting nuclear proteins.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.